{"title": "Targeting Production of Reactive Oxygen Species as an Anticancer Strategy", "author": "GRIGORIA-KALLIOPI MARIOLI-SAPSAKOU; MALAMATI KOURTI", "url": "https://ar.iiarjournals.org/content/41/12/5881", "hostname": "iiarjournals.org", "description": "Cancer remains the second leading cause of death worldwide. Research is currently focused on finding novel anticancer therapies and elucidating their mechanisms of action. Cellular redox balance is a promising target for new therapies, as cancer cells already have elevated levels of oxidizing agents due to hypermetabolism and genetic instability. Although free radicals are actively involved in vital cellular signaling pathways, they have also been implicated in certain diseases, including cancer. The aim of this review was to highlight the involvement of oxidative stress in the mechanism of action of anticancer agents. The difference in cellular redox balance between normal and cancer cells is discussed as a potential anticancer target, along with various examples of approved or experimental drugs that may alter the redox state. These drugs are presented in relation to their pro-oxidant or antioxidant mechanisms, with the consequent goal of underscoring the importance of such mechanisms in the overall efficacy of anticancer drugs.", "sitename": "Anticancer Research", "date": "2021-12-01", "cleaned_text": "Abstract Cancer remains the second leading cause of death worldwide. Research is currently focused on finding novel anticancer therapies and elucidating their mechanisms of action. Cellular redox balance is a promising target for new therapies, as cancer cells already have elevated levels of oxidizing agents due to hypermetabolism and genetic instability. Although free radicals are actively involved in vital cellular signaling pathways, they have also been implicated in certain diseases, including cancer. The aim of this review was to highlight the involvement of oxidative stress in the mechanism of action of anticancer agents. The difference in cellular redox balance between normal and cancer cells is discussed as a potential anticancer target, along with various examples of approved or experimental drugs that may alter the redox state. These drugs are presented in relation to their pro-oxidant or antioxidant mechanisms, with the consequent goal of underscoring the importance of such mechanisms in the overall efficacy of 2021. - Revision received September 13, 2021. - Accepted September 17, 2021. - Copyright \u00a9 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved. [View Full Text](https://ar.iiarjournals.org/content/41/12/5881.full) This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased. Log in using your username and password Purchase access [create an account](/user/register)if you don't already have one. patientACCESS [patientACCESS](https://s100.copyright.com/AppDispatchServlet?publisherName=&publication=&title=Targeting%20Production%20of%20Reactive%20Oxygen%20Species%20as%20an%20Anticancer%20Strategy&publicationDate=2021-12-01&author=GRIGORIA-KALLIOPI%20MARIOLI-SAPSAKOU%2CMALAMATI%20KOURTI&contentID=anticanres%3B41/12/5881&volumeNum=41&issueNum=12&startPage=5881&endPage=5902&numPages=22\u00a9right=Copyright%20%C2%A9%202021%20International%20Institute%20of%20Anticancer%20Research%20%28Dr.%20George%20J.%20Delinasios%29%2C%20All%20rights%20reserved.&orderBeanReset=true&pa=yes)- Patients desiring access to articles "}